Clinical trials
Phase 2/3 Insulin Resistance trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 5 |
| 2014 | 4 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 6 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 5 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 3 |
| Massachusetts General Hospital | 3 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| The University of Texas Medical Branch, Galveston | 2 |
| University of Campinas, Brazil | 2 |
| University of Guadalajara | 2 |
| Ain Shams University | 1 |
| All India Institute of Medical Sciences | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Austin Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 41 |
| Diabetes Mellitus, Type 1 | 8 |
| Diabetes Mellitus, Type 2 | 8 |
| Obesity | 7 |
| Diabetes Mellitus | 6 |
| Metabolic Syndrome | 3 |
| Atherosclerosis | 2 |
| Burns | 2 |
| Cardiovascular Diseases | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.